A little over a year ago, in
July, 2012, a Stryker recall was issued for the Rejuvenate and ABGII hip
implant devices. These implants fell under a Stryker recall due to the risks of
fretting and corrosion which could lead to the release of metal ions into the
body and failure of the hip implant. When a hip implant fails, revision surgery
becomes necessary—an expensive and potentially risky procedure. Nearly 20,000
people were implanted with a Rejuvenate or ABGII hip device prior to the
Stryker recall. These people hoped to have the quality of their life improved
through being able to achieve greater mobility. When the Stryker recall was issued,
the hopes of many of those people were dashed.
Of course prior to the Stryker
recall, many recipients had already suffered serious adverse health effects
from their Stryker hip. Stryker advertised this innovative new design as
potentially lasting 15-20 years, saving many people from ever having to have
their hip implant replaced. Unfortunately, following the Stryker recall, most
recipients realized they would likely not have their Stryker hip implant
anywhere close to that long. In fact, at the time of the Stryker recall, the
company refused to put a number on the risk of failure, but later, independent
studies placed that risk as high as 40%.What this meant for those subject to
the Stryker recall, is that those patients who had not yet had trouble with
their implant likely would in the
near future.
Although the Stryker recall
lumped the two hip devices together, there are some differences. The ABGII has
a shorter stem, and is covered with a shallower layer of hydroxyapatite porous
coating, making it somewhat easier to remove than the Rejuvenate. The neck
piece of both models is constructed of cobalt and chromium and the stem is
titanium,however the metals are in slightly different proportions. The Stryker
recall meant that many implant recipients were forced to see their doctor to
have their levels of cobalt and chromium tested as well as to speak to a
Stryker recall attorney to explore future options. After all, the Stryker
recall caused many patients to be left with huge medical expenses and lost
wages from being unable to return to work. Many of these patients suffered
substantial amounts of chronic pain, as well as significant levels of emotional
suffering. The Stryker recall is likely to have long-term repercussions for
many recipients of a Rejuvenate or ABGII.
No comments:
Post a Comment